phytopharm will receive an initial fee of 6.5m from unilever out of a potential total of 21m as well as future royalties on product sales.under the deal, production of the hoodia cactus at phytopharm's nursery in south africa will also rise from eight million plants to potentially hundreds of millions, said phytopharm chief executive richard dixey.the firm had initially hoped to market a slimming drug from hoodia with pfizer.analysts said unilever could launch the new products in 2007.